Atlas Trials

Incidence of Hemocompatibility Events With or Without Aspirin in Patients With CH-VAD

Clinical trial NCT07343102 · COMPLETED

Trial details

NCT number
NCT07343102
Sponsor
China National Center for Cardiovascular Diseases
Status
COMPLETED
Study type
OBSERVATIONAL
Hemocompatibility-related Adverse Event
Start date
2022-08-01
Primary completion
2025-11-20
Enrollment
220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.